Results 141 to 150 of about 10,843 (242)

Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021
N. P. Morales, Supot Rodrat, Pannaree Piromkraipak, Paveena Yamanont, K. Paiboonsukwong, S. Fucharoen   +5 more
semanticscholar   +1 more source

Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone

, 2009
Paul Telfer, F. G. Warburton, Soteroula Christou, M Hadjigavriel, Maria Sitarou, Anita Kolnagou, M. Angastiniotis   +6 more
openalex   +2 more sources

4094MRI prospective survey on heart and liver iron and cardiac function in thalassemia major patients treated with Deferasirox versus Deferiprone and Desferrioxamine in monotherapy [PDF]

, 2017
Antonella Meloni, Laura Pistoia, Stefania Renne, Gennaro Restaino, Antonino Vallone, Alessandra Olivi, Angelica Barone, Massimo Allò, Domenico Maddaloni, Cosimo De Bari, Vincenzo Positano, Alessia Pepe   +11 more
openalex   +1 more source

Randomized Controlled Trial of the Efficacy and Safety of Deferiprone: Subgroup Analysis of Pediatric Patients in Iron-Overloaded Patients with Sickle Cell Disease and Other Anemias

, 2021
Mona Hamdy, Amal El‐Beshlawy, Fatma Soliman Elsayed Ebeid, Janet L. Kwiatkowski, Julie Kanter, Baba Inusa, Suzan Williams, David Lee, Noemi Toiber Temin, Caroline Fradette, Fernando Tricta, Mohsen Saleh Elalfy   +11 more
openalex   +1 more source

Reduction of oxidative stress in total knee arthroplasty using tourniquet with a novel pharmaceutical combination. [PDF]

SICOT J
Tatani I, Kalaitzopoulou E, Skipitari M, Ntoukas A, Tsaliki EA, Giakoumakis S, Lakoumentas J, Varemmenou A, Michail E, Papadea P, Georgiou CD, Panagiotopoulos E.   +11 more
europepmc   +1 more source

Deferiprone has anti-inflammatory properties and reduces fibroblast migration in vitro [PDF]

, 2019
Mahnaz Ramezanpour, Jason Smith, Mian Li Ooi, Michael Gouzos, Alkis J. Psaltis, Peter‐John Wormald, Sarah Vreugde   +6 more
openalex   +1 more source

A Prospective Randomized Multicenter Trial Using Either Deferiprone or Deferasirox after an Early Start of Deferiprone or Placebo in Young Children Newly Diagnosed with Transfusion-Dependent Beta-Thalassemia

, 2021
Mohsen Saleh Elalfy, Amira Adly, Fatma Soliman Elsayed Ebeid, Amal El‐Beshlawy, Niveen Salama, Mona Hamdy   +5 more
openalex   +1 more source

Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease [PDF]

, 2016
AVILIA, SIMONA, CATALANO, LUCIO, CERCHIONE, CLAUDIO, Cerciello, Giuseppe, DELLA PEPA, ROBERTA, Pane, Fabrizio, PICARDI, MARCO, PUGLIESE, NOVELLA   +7 more
core   +1 more source

Deferiprone Related Arthropathy in 11-Year-Old Boy with Hereditary Spherocytosis [PDF]

, 2019
Ye Kyeng Seo, Jong Kyu Han, Won Suk Suh, Kyeong Bae Park   +3 more
openalex   +1 more source

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

, 2022
Baba Inusa, Mona Hamdy, Amal El‐Beshlawy, Fatma Soliman Elsayed Ebeid, Janet Kwiatkowski, J. Kanter, Sophia Williams, D Lee, Noemi Toiber Temin, Caroline Fradette, Fernando Tricta, Mohsen Saleh Elalfy   +11 more
openalex   +1 more source